A61K 49/1896
Not provided for elsewhere
Official title: {not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides}
A61K49/1896 (Not provided for elsewhere) appears on 88 US grants and 159 published applications in this corpus.
Search patents in A61K- Granted patents
- 88
- Published applications
- 159
- Assignees
- 82
- Inventors
- 301
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 1 | 5 |
| 2004 | 0 | 5 |
| 2005 | 1 | 4 |
| 2006 | 0 | 6 |
| 2007 | 1 | 7 |
| 2008 | 2 | 2 |
| 2009 | 0 | 13 |
| 2010 | 1 | 8 |
| 2011 | 5 | 9 |
| 2012 | 5 | 8 |
| 2013 | 5 | 4 |
| 2014 | 4 | 1 |
| 2015 | 4 | 7 |
| 2016 | 6 | 10 |
| 2017 | 5 | 5 |
| 2018 | 5 | 8 |
| 2019 | 5 | 6 |
| 2020 | 2 | 8 |
| 2021 | 7 | 13 |
| 2022 | 6 | 8 |
| 2023 | 4 | 7 |
| 2024 | 2 | 5 |
| 2025 | 4 | 2 |
| 2026 | 4 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of suppressing delivery of exosomes to liver and spleen12 May 2026US 12,622,876 B2Lonza Sales AG
- Therapeutic use of mitochondria and combined mitochondrial agents14 Apr 2026US 12,600,800 B2Beth Israel Deaconess Medical Center, Inc.
- Systems and methods for using improved contrast agent in performing and MRI20 Jan 2026US 12,529,737 B2
- Nanocarrier systems for imaging and delivery of active agents6 Jan 2026US 12,514,935 B2Kansas State University Research Foundation
- Cellular targeted label delivery system2 Dec 2025US 12,485,192 B2Cellis AG
- Anti-cancer strain secreting streptavidin-fusion protein having biotin binding ability, anti-cancer composition using the same, anti-cancer adjuvant and tumor imaging agent27 Aug 2026US 2026/0250336 A1Korea Institute of Science and Technology
- Nanosheet-hydrogel composites and methods of us30 Jul 2026US 2026/0216095 A1Rutgers, The State University of New Jersey
- Imaging phantom21 May 2026US 2026/0137816 A1The Regents of the University of Michigan
- System for focused targeting of magneto-aerotactic-responsive bacteria and method of use thereof16 Apr 2026US 2026/0102496 A1Starpax Biopharma Inc.
- Biocompatible parahydrogen hyperpolarized solutions by precipitation and re-dissolution19 Feb 2026US 2026/0048155 A1
Most cited
By later US patents
- Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles105US 5,667,764 AZynaxis, Inc. · 1997
- Glycoconjugates and methods56US 6,075,134 AThe Regents of the University of California · 2000
- Glycoconjugates and methods51US 6,458,937 B1The Regents of the University of California · 2002
- Modified vaccinia virus strains for use in diagnostic and therapeutic methods40US 8,052,968 B2Genelux Corporation · 2011
- Methods, reagents and test kits for determination of subpopulations of biological entities36US 5,256,532 AZynaxis Technologies, Inc. · 1993